-- 
Areva, BioAlliance, Legrand, Robertet: French Equity Preview

-- B y   A l a n   K a t z   a n d   M a r t h e   F o u r c a d e
-- 
2011-03-04T05:00:01Z

-- http://www.bloomberg.com/news/2011-03-04/areva-bioalliance-legrand-robertet-french-equity-preview.html
The following is a list of companies
that may have unusual share-price changes in Paris. Stock
symbols are in parentheses after company names. Share prices are
from the last close.  France’s  CAC 40 Index (CAC)  rose 26.44, or 0.7 percent, to
4,060.76 in Paris. The SBF-120 Index gained 0.6 percent.    Areva SA (CEI)  : The biggest supplier of nuclear fuel and
services scrapped its dividend payout for 2010 and reported
full-year profit that missed estimates on charges. Net income
rose 60 percent to 883 million euros, less than the 1.06
billion-euro estimate in a Bloomberg survey of analysts. The
shares fell 3.7 percent to 33.55 euros.    BioAlliance Pharma SA (BIO)  : The pharmaceutical company
said net income last year was 2.81 million euros, compared with
a loss of 15.4 million euros a year earlier. The shares rose 2
percent to 6 euros.    Legrand SA (LR)  : Kohlberg Kravis Roberts & Co. and  Wendel (MF)   said they plan to sell 40 million shares in the
world’s largest maker of wiring devices such as plugs and
switches, equivalent to a 15 percent stake in the company.
Legrand shares fell 0.1 percent to 30.29 euros.    Robertet SA (RBT)  : The maker of liquid flavorings,
perfumes and aromatic ingredients said profit last year rose to
about 23 million euros from 14.4 million euros in 2009. The
stock fell 0.5 percent to 115.50 euros.  To contact the reporters on this story:
Alan Katz in Paris at   akatz5@bloomberg.net .
Marthe Fourcade in Paris at 
 mfourcade@bloomberg.net   To contact the editor responsible for this story:
Vidya Root at   vroot@bloomberg.net  